Brief: Aim Immunotech And Japanese National Institute Of Infectious Disease Enters Into A Material Transfer And Research Agreement
30/05/2023 12:57
May 30 (Reuters) - AIM ImmunoTech Inc AIM.A :
* AIM IMMUNOTECH INC - ON MAY 22 CO AND JAPANESE NATIONAL
INSTITUTE OF INFECTIOUS DISEASE ENTERED INTO A MATERIAL TRANSFER
AND RESEARCH AGREEMENT
Further company coverage: AIM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential